ロード中...
Recurrence-Free Survival of a Hepatocellular Carcinoma Patient With Tumor Thrombosis of the Inferior Vena Cava After Treatment With Sorafenib and Hepatic Resection
Sorafenib (Nexabar, Bayer, Berlin, Germany), one of multikinase inhibitors, can infrequently downstage advanced hepatocellular carcinoma (HCC). There are some reports that sorafenib in combination with other modalities, such as transcatheter arterial chemoembolization (TACE) or radiation therapy, co...
保存先:
| 出版年: | Int Surg |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The International College of Surgeons, World Federation of General Surgeons and Surgical Specialists, Inc.
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4452982/ https://ncbi.nlm.nih.gov/pubmed/26011214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9738/INTSURG-D-14-00133.1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|